Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20841 | 25697114 | Med Hypotheses | Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH. | 2015 | Details |
| A20842 | 25694178 | Expert Rev Gastroenterol Hepatol | Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. | 2015 | Details |
| A20843 | 25693058 | J Hypertens | Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk. | 2015 | Details |
| A20844 | 25690689 | Abdom Imaging | Ultrasound elastography: liver. | 2015 | Details |
| A20845 | 25690590 | Curr Atheroscler Rep | FXR agonists as therapeutic agents for non-alcoholic fatty liver disease. | 2015 | Details |
| A20846 | 25690560 | Eur J Clin Invest | Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. | 2015 | Details |
| A20847 | 25690422 | Nutrients | Low-normal thyroid function and novel cardiometabolic biomarkers. | 2015 | Details |
| A20848 | 25689614 | Liver Int | Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease. | 2015 | Details |
| A20849 | 25688578 | Hemodial Int | Relationship between non-alcoholic fatty liver disease and MIA syndrome. | 2015 | Details |
| A20851 | 25686742 | Dig Dis Sci | Prevalence of Insulin Resistance in Subjects with Nonalcoholic Fatty Liver Disease and Its Predictors in a Chinese Population. | 2015 | Details |
| A20852 | 25684943 | World J Gastroenterol | In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM. | 2015 | Details |
| A20853 | 25684936 | World J Gastroenterol | Vitamin D: a new player in non-alcoholic fatty liver disease? | 2015 | Details |
| A20854 | 25684933 | World J Gastroenterol | Gut microbiota and liver diseases. | 2015 | Details |
| A20855 | 25684563 | J Gastroenterol Hepatol | Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis. | 2015 | Details |
| A20856 | 25683947 | Eur Rev Med Pharmacol Sci | Serum uric acid and non-alcoholic fatty liver disease in non-hypertensive Chinese adults: the Cardiometabolic Risk in Chinese (CRC) study. | 2015 | Details |
| A20857 | 25683387 | Atherosclerosis | The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). | 2015 | Details |
| A20858 | 25683343 | Diabet Med | Practical approach to non-alcoholic fatty liver disease in patients with diabetes. | 2015 | Details |
| A20859 | 25681756 | Exp Mol Pathol | Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis. | 2015 | Details |
| A20861 | 25681399 | Gut | Pathobiology of liver fibrosis: a translational success story. | 2015 | Details |
| A20862 | 25681381 | Clin Infect Dis | Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy. | 2015 | Details |
| A20864 | 25678995 | Med J Islam Repub Iran | A diagnostic model for cirrhosis in patients with non-alcoholic fatty liver disease: an artificial neural network approach. | 2014 | Details |
| A20866 | 25678388 | J Hepatol | Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutations. | 2015 | Details |
| A20868 | 25677815 | Digestion | Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women. | 2015 | Details |
| A20870 | 25676019 | Front Med | Metformin and metabolic diseases: a focus on hepatic aspects. | 2015 | Details |
| A20871 | 25672270 | Int J Mol Med | MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis. | 2015 | Details |
| A20873 | 25671838 | Ann Hepatol | Enterococcus casseliflavus and Enterococcus gallinarum as causative agents of spontaneous bacterial peritonitis. | 2015 | Details |
| A20874 | 25671834 | Ann Hepatol | Granulocyte-colony stimulating factor prevents the development of hepatic steatosis in rats. | 2015 | Details |
| A20875 | 25671801 | Horm Metab Res | Does metformin treatment influence bone formation in patients with nonalcoholic fatty liver disease? | 2015 | Details |
| A20876 | 25671200 | J Exerc Nutrition Biochem | Effect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL/6 mice. | 2014 | Details |
| A20877 | 25670619 | Arab J Gastroenterol | Effects of fenugreek, Nigella, and termis seeds in nonalcoholic fatty liver in obese diabetic albino rats. | 2015 | Details |
| A20878 | 25669689 | Physiol Res | Peroxisomal enzymes in the liver of rats with experimental diabetes mellitus type 2. | 2014 | Details |
| A20879 | 25669174 | Clin Pharmacol Ther | Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis. | 2015 | Details |
| A20880 | 25668433 | PLoS Negl Trop Dis | Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders. | 2015 | Details |
| A20881 | 25667378 | Endocr Pract | RELATIVE CONTRIBUTIONS OF ECTOPIC LIVER AND ABDOMINAL FAT ACCUMULATION TO ARTERIAL STIFFNESS. | 2015 | Details |
| A20882 | 25666645 | Nat Rev Gastroenterol Hepatol | NAFLD. Accurate quantification of hepatic fat--is it important? | 2015 | Details |
| A20883 | 25666017 | J Hepatol | Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity. | 2015 | Details |
| A20884 | 25665792 | Am J Pathol | Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway. | 2015 | Details |
| A20885 | 25664838 | Nutr Diabetes | Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity. | 2015 | Details |
| A20886 | 25664055 | Int J Clin Exp Med | Sonographic assessment of fatty liver: intraobserver and interobserver variability. | 2014 | Details |
| A20887 | 25663786 | World J Gastroenterol | Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. | 2015 | Details |
| A20888 | 25661699 | Int Immunopharmacol | Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats. | 2015 | Details |
| A20889 | 25661453 | Clin Gastroenterol Hepatol | Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20890 | 25659874 | Atheroscler Suppl | The effect of ezetimibe on NAFLD. | 2015 | Details |
| A20893 | 25658689 | PLoS One | Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis. | 2015 | Details |
| A20894 | 25658238 | Nutrients | 6-gingerol protects against nutritional steatohepatitis by regulating key genes related to inflammation and lipid metabolism. | 2015 | Details |
| A20895 | 25657751 | J Res Med Sci | The relationship between resistin and ghrelin levels with fibrosis in nonalcoholic fatty liver disease. | 2014 | Details |
| A20896 | 25655997 | J Ethnopharmacol | Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice. | 2015 | Details |
| A20897 | 25655569 | J Cell Physiol | The SRE Motif in the Human PNPLA3 Promoter (-97 to -88 bp) Mediates Transactivational Effects of SREBP-1c. | 2015 | Details |
| A20898 | 25655287 | Hepatobiliary Pancreat Dis Int | Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases. | 2015 | Details |
| A20899 | 25655252 | Postgrad Med J | Republished: Non-alcoholic fatty liver disease: a practical approach to treatment. | 2015 | Details |
| A20901 | 25654388 | Medicine (Baltimore) | Nonalcoholic fatty liver disease: a negative risk factor for colorectal cancer prognosis. | 2015 | Details |
| A20902 | 25654291 | Zhonghua Gan Zang Bing Za Zhi | [Impact of JNK inhibitor XG-102 in a diet-induced rat model of non-alcoholic steatohepatitis]. | 2014 | Details |
| A20903 | 25654290 | Zhonghua Gan Zang Bing Za Zhi | [Association of intestinal epithelial tight junctions, E.coli, intestinal mucosa Toll-like receptor-4 and tumor necrosis factor-alpha in rabbit with non-alcoholic fatty liver disease]. | 2014 | Details |
| A20904 | 25654287 | Zhonghua Gan Zang Bing Za Zhi | [A multi-center clinical study of a novel controlled attenuation parameter for assessment of fatty liver]. | 2014 | Details |
| A20905 | 25654080 | Front Med (Lausanne) | Management of moderate to severe psoriasis in patients with metabolic comorbidities. | 2015 | Details |
| A20906 | 25651169 | Cell Metab | Turn up the heat: circulating serotonin tunes our internal heating system. | 2015 | Details |
| A20907 | 25649235 | Eur J Clin Nutr | Dietary patterns are associated with prevalence of fatty liver disease in adults. | 2015 | Details |
| A20908 | 25649191 | Obes Res Clin Pract | Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatment. | 2015 | Details |
| A20909 | 25648740 | Eur J Nutr | Self-reported eating speed in relation to non-alcoholic fatty liver disease in adults. | 2015 | Details |
| A20910 | 25648511 | Mar Drugs | Seaweed supplements normalise metabolic, cardiovascular and liver responses in high-carbohydrate, high-fat fed rats. | 2015 | Details |
| A20913 | 25647178 | PLoS One | High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload. | 2015 | Details |
| A20914 | 25646890 | J Hepatol | Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC. | 2015 | Details |
| A20915 | 25646886 | J Hepatol | Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance. | 2015 | Details |
| A20916 | 25646773 | PLoS One | Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. | 2015 | Details |
| A20917 | 25646700 | Liver Int | Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis. | 2015 | Details |
| A20918 | 25646328 | Am J Clin Nutr | Isoleucine-to-methionine substitution at residue 148 variant of PNPLA3 gene and metabolic outcomes in gestational diabetes. | 2014 | Details |
| A20920 | 25645621 | Biochim Biophys Acta | PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro. | 2015 | Details |
| A20921 | 25644696 | Sci Rep | Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. | 2015 | Details |
| A20922 | 25643684 | Gac Med Mex | [Hepatic steatosis (HS) as a factor associated with the presence of metabolic risk in schoolchildren and obese adolescents]. | 2014 | Details |
| A20923 | 25643676 | Gac Med Mex | [Dietary patterns and physical activity in the mexican population: association with fatty liver]. | 2014 | Details |
| A20924 | 25641744 | J Gastroenterol Hepatol | PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis. | 2015 | Details |
| A20926 | 25637246 | Mol Genet Metab | Aldolase-B knockout in mice phenocopies hereditary fructose intolerance in humans. | 2015 | Details |
| A20927 | 25636888 | Phytomedicine | Two cinnamoyloctopamine antioxidants from garlic skin attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis. | 2014 | Details |
| A20928 | 25634759 | Cell Physiol Biochem | Human sterol regulatory element-binding protein 1a contributes significantly to hepatic lipogenic gene expression. | 2015 | Details |
| A20929 | 25634387 | Indian Heart J | Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α. | 2014 | Details |
| A20930 | 25633908 | Health Technol Assess | Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. | 2015 | Details |
| A20931 | 25633064 | Arch Dis Child | Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. | 2015 | Details |
| A20932 | 25632750 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Effect of Shugan Jianpi Recipe on LXRα/FAS signaling pathway mediated hepatocyte fatty deposits in NAFLD rats]. | 2014 | Details |
| A20934 | 25632192 | World J Gastroenterol | Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease. | 2015 | Details |
| A20935 | 25632188 | World J Gastroenterol | Factors associated with significant liver fibrosis assessed using transient elastography in general population. | 2015 | Details |
| A20936 | 25632182 | World J Gastroenterol | Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease. | 2015 | Details |
| A20938 | 25631376 | IUBMB Life | Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver disease. | 2015 | Details |
| A20939 | 25629574 | Eur J Gastroenterol Hepatol | Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20940 | 25627311 | Liver Int | Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects. | 2014 | Details |
| A20942 | 25624996 | World J Hepatol | Adiponectin serum level in chronic hepatitis C infection and therapeutic profile. | 2015 | Details |
| A20943 | 25624725 | World J Gastroenterol | Association of nonalcoholic fatty liver disease and liver cancer. | 2015 | Details |
| A20944 | 25624712 | World J Gastroenterol | PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis. | 2015 | Details |
| A20945 | 25623824 | J Hepatol | Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis. | 2015 | Details |
| A20946 | 25623823 | J Hepatol | Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds. | 2015 | Details |
| A20947 | 25623289 | J Transl Med | Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles. | 2015 | Details |
| A20948 | 25622927 | J Gastroenterol | Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. | 2015 | Details |
| A20949 | 25622557 | Int J Biochem Cell Biol | Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver disease. | 2015 | Details |
| A20950 | 25621497 | J Clin Invest | Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease. | 2015 | Details |
| A20951 | 25620624 | J Magn Reson Imaging | Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects. | 2015 | Details |
| A20953 | 25619540 | Curr Diabetes Rev | Is type 2 diabetes mellitus a predisposal cause for developing hepatocellular carcinoma? | 2015 | Details |
| A20955 | 25619308 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease comorbid with major depressive disorder: The pathological features and poor therapeutic efficacy. | 2015 | Details |
| A20957 | 25617860 | Atherosclerosis | A concise review of non-alcoholic fatty liver disease. | 2015 | Details |
| A20958 | 25617505 | J Hepatol | Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease. | 2015 | Details |
| A20959 | 25617503 | J Hepatol | Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity. | 2015 | Details |
| A20962 | 25617409 | G3 (Bethesda) | Identification of eQTLs for hepatic Xbp1s and Socs3 gene expression in mice fed a high-fat, high-caloric diet. | 2015 | Details |